RetiSpec

RetiSpec is rated 3 out of 5 in the category medical devices. Read and write reviews about RetiSpec. RetiSpec is a medical imaging company developing a tool for the early detection of Alzheimer’s disease biomarkers in the eye. Our goal is to enable widespread early detection of Alzheimer’s disease with accessible and scalable screening. The company is headquartered in Toronto, Canada, and is part of the Ontario Brain Institute (OBI), Biomedical Zone, NEXT Canada, Ontario Centre of Excellence and The Centre for Aging and Brain Health Innovation (CABHI)’s network of companies.